Navigation Links
No Blood Needed Thanks to Innovative Medical Technology
Date:9/26/2008

SYDNEY, Australia, Sept. 26 /PRNewswire/ -- A non-invasive blood monitoring device that removes the need to draw blood to monitor patients has won the 2008 Kerrin Rennie Award for Excellence in Medical Technology. The award was presented to Masimo Corporation on 24 September at the Medical Technology Association of Australia (MTAA) dinner in Sydney.

The Radical-7 Pulse CO-Oximeter from Masimo Corporation continuously and non-invasively measures blood constituents in patients without having to draw blood. The device uses multiple wavelengths of light in a single, simple to apply sensor. It can be used reliably in different care settings, for example at the patient's bedside or during transport.

In addition to its unique use of algorithms to ensure accurate patient monitoring, the Radical-7 includes a unique technology platform that allows for additional features to be added as simple software upgrades.

In congratulating the winner, Anne Trimmer, MTAA CEO, said: "Masimo's Oximeter is an excellent example of innovation in the medical technology sector. It benefits the patient, the clinician and the health system."

The Kerrin Rennie Award for Excellence in Medical Technology -- Improving Quality of Life recognises the innovative and extraordinary contribution of medical technology in improving health outcomes of Australian patients.

The award dinner was held as part of a two-day conference on medical technology from Wednesday 24 - Thursday 25 September at Star City in Sydney. Companies could enter products launched in Australia between 1 January 2007 and 1 August 2008 used in the diagnosis, prevention, treatment or management of disease and disability. Entries were judged by an independent panel.

The other finalists are:

Ex-Press Shunt -- Device Technologies

The Ex-Press miniature glaucoma shunt is an implant used to drain off excess fluid in the eye and to reduce intraocular pressure. The device creates a permanent pathway for excess fluid to drain from the eye and maintains a more normal pressure in the eye. The Ex-Press Shunt is an improved technology that causes less post operative trauma and fewer adverse events.

HCO 1100 Protein Permeable Membrane -- Gambro

The HCO 1100 Protein-Permeable Membrane is designed to improve the treatment of multiple myeloma patients with acute renal failure by removing larger molecules from blood particularly serum Free Light Chains (FLC), the protein present at abnormally high concentrations in this patient group. High levels of FLCs in the blood circulating through the kidney present a major cause of renal impairment. This new membrane technology in combination with chemotherapy can prevent the patient from developing end stage renal disease and having to rely on dialysis for survival.

The Medical Technology Association of Australia (MTAA) is the national peak industry body representing companies in the medical technology industry. MTAA aims to ensure the benefits of modern, innovative and reliable medical technologyare delivered to the community for a healthier Australia. http://www.mtaa.org.au

Media contact: Marion Demann MTAA 0416 625 678


'/>"/>
SOURCE The Medical Technology Association of Australia
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Human Trial Results Show Plant Extract Tops Drug at Regulating Blood Sugar Levels; Huge Market Seen for Newly Developed Food Additive Emulin™
2. Sanofi Aventis : New Study Results Support the "Basal Plus" Strategy With LANTUS(R) and APIDRA(R) to Improve Blood Sugar Control in Patients With Type 2 Diabetes
3. Limbs saved by menstrual blood stem cells
4. Biotest Diagnostics Receives FDA Clearance for Full Line of Traditional Blood Bank Reagents
5. FDA Grants Full Approval of PROCLEIX(R) ULTRIO(R) Blood Screening Assay
6. New CO-oximetry Module for the ABL80 FLEX Blood Gas Analyzer
7. Chest Physicians Now Suggest Early Intervention for Certain Blood Clots in DVT
8. GeneNews launches worlds first blood test for colorectal cancer screening
9. Anesiva Launches Needle-Free Zingo(TM) to Reduce Pain from IV Starts and Blood Draws in Children
10. ProMetic announces Octapharma publication of PRDTS prion removal resin in Octaplas(R) manufacturing process at 30th International Congress of the International Society for Blood Transfusion meeting in Macao SAR, China
11. InterCure Supports AHA Endorsement of Home Blood Pressure Monitoring
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... ... June 24, 2016 , ... While the majority of commercial spectrophotometers and fluorometers ... the 6000i models are higher end machines that use the more unconventional z-dimension of ... beam from the bottom of the cuvette holder. , FireflySci has developed several ...
(Date:6/23/2016)... 2016 /PRNewswire/ - FACIT has announced the creation ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" or "the ... a portfolio of first-in-class WDR5 inhibitors for the ... WDR5 represent an exciting class of therapies, possessing ... for cancer patients. Substantial advances have been achieved ...
(Date:6/23/2016)... 2016  The Biodesign Challenge (BDC), a university competition ... harness living systems and biotechnology, announced its winning teams ... New York City . The ... projects at MoMA,s Celeste Bartos Theater during the daylong ... senior curator of architecture and design, and Suzanne ...
(Date:6/23/2016)... Apellis Pharmaceuticals, Inc. today announced positive ... its complement C3 inhibitor, APL-2. The trials were ... studies designed to assess the safety, tolerability, pharmacokinetics ... healthy adult volunteers. Forty subjects were ... dose (ranging from 45 to 1,440mg) or repeated ...
Breaking Biology Technology:
(Date:3/31/2016)... R.I. , March 31, 2016  Genomics firm ... of founding CEO, Barrett Bready , M.D., who ... members of the original technical leadership team, including Chief ... President of Product Development, Steve Nurnberg and Vice President ... returned to the company. Dr. Bready served ...
(Date:3/23/2016)... March 23, 2016 ... Sicherheit Gesichts- und Stimmerkennung mit Passwörtern ... (NASDAQ: MESG ), ein führender Anbieter ... Unternehmen mit SpeechPro zusammenarbeitet, um erstmals dessen ... wird die Möglichkeit angeboten, im Rahmen mobiler ...
(Date:3/22/2016)... Ontario , PROVO and ... Newborn Screening Ontario (NSO), which operates the ... for molecular testing, and Tute Genomics and UNIConnect, ... management technology respectively, today announced the launch of a ... next-generation sequencing (NGS) testing panel. NSO ...
Breaking Biology News(10 mins):